Cooper ROA 2010-2024 | COO
Current and historical return on assets (ROA) values for Cooper (COO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Cooper ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-01-31 |
$0.29B |
$12.03B |
2.48% |
| 2023-10-31 |
$0.30B |
$11.66B |
2.54% |
| 2023-07-31 |
$0.28B |
$11.70B |
2.38% |
| 2023-04-30 |
$0.29B |
$11.54B |
2.51% |
| 2023-01-31 |
$0.38B |
$11.56B |
3.24% |
| 2022-10-31 |
$0.39B |
$11.49B |
3.32% |
| 2022-07-31 |
$0.43B |
$11.55B |
3.86% |
| 2022-04-30 |
$0.95B |
$11.78B |
8.89% |
| 2022-01-31 |
$0.94B |
$11.66B |
9.41% |
| 2021-10-31 |
$2.95B |
$9.61B |
31.71% |
| 2021-07-31 |
$2.92B |
$9.61B |
34.02% |
| 2021-04-30 |
$2.36B |
$9.01B |
29.98% |
| 2021-01-31 |
$2.25B |
$8.92B |
31.11% |
| 2020-10-31 |
$0.24B |
$6.74B |
3.60% |
| 2020-07-31 |
$0.28B |
$6.75B |
4.28% |
| 2020-04-30 |
$0.34B |
$6.51B |
5.39% |
| 2020-01-31 |
$0.45B |
$6.55B |
7.21% |
| 2019-10-31 |
$0.47B |
$6.28B |
7.47% |
| 2019-07-31 |
$0.45B |
$6.17B |
7.20% |
| 2019-04-30 |
$0.43B |
$6.20B |
6.87% |
| 2019-01-31 |
$0.37B |
$6.30B |
5.84% |
| 2018-10-31 |
$0.14B |
$6.11B |
2.24% |
| 2018-07-31 |
$0.13B |
$6.26B |
2.15% |
| 2018-04-30 |
$0.13B |
$6.41B |
2.35% |
| 2018-01-31 |
$0.18B |
$6.27B |
3.39% |
| 2017-10-31 |
$0.37B |
$4.86B |
7.85% |
| 2017-07-31 |
$0.35B |
$4.78B |
7.41% |
| 2017-04-30 |
$0.33B |
$4.75B |
7.14% |
| 2017-01-31 |
$0.30B |
$4.66B |
6.52% |
| 2016-10-31 |
$0.27B |
$4.48B |
6.06% |
| 2016-07-31 |
$0.25B |
$4.59B |
5.54% |
| 2016-04-30 |
$0.21B |
$4.60B |
4.63% |
| 2016-01-31 |
$0.19B |
$4.40B |
4.39% |
| 2015-10-31 |
$0.20B |
$4.46B |
4.63% |
| 2015-07-31 |
$0.20B |
$4.42B |
4.50% |
| 2015-04-30 |
$0.24B |
$4.39B |
5.82% |
| 2015-01-31 |
$0.26B |
$4.34B |
6.73% |
| 2014-10-31 |
$0.27B |
$4.46B |
7.63% |
| 2014-07-31 |
$0.30B |
$3.37B |
9.22% |
| 2014-04-30 |
$0.30B |
$3.22B |
9.52% |
| 2014-01-31 |
$0.29B |
$3.12B |
9.59% |
| 2013-10-31 |
$0.30B |
$3.14B |
9.80% |
| 2013-07-31 |
$0.31B |
$3.01B |
10.47% |
| 2013-04-30 |
$0.29B |
$2.97B |
9.83% |
| 2013-01-31 |
$0.27B |
$2.97B |
9.42% |
| 2012-10-31 |
$0.25B |
$2.94B |
9.01% |
| 2012-07-31 |
$0.23B |
$2.88B |
8.72% |
| 2012-04-30 |
$0.21B |
$2.63B |
8.06% |
| 2012-01-31 |
$0.19B |
$2.60B |
7.30% |
| 2011-10-31 |
$0.18B |
$2.63B |
6.71% |
| 2011-07-31 |
$0.17B |
$2.62B |
6.42% |
| 2011-04-30 |
$0.16B |
$2.63B |
6.34% |
| 2011-01-31 |
$0.13B |
$2.57B |
5.18% |
| 2010-10-31 |
$0.11B |
$2.53B |
4.45% |
| 2010-07-31 |
$0.09B |
$2.50B |
3.73% |
| 2010-04-30 |
$0.08B |
$2.51B |
2.99% |
| 2010-01-31 |
$0.10B |
$2.52B |
3.80% |
| 2009-10-31 |
$0.10B |
$2.55B |
3.95% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.874B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
